Status:
RECRUITING
Comparison of Application Effects Between Long- and Standard Short- Peripheral Venous Catheters
Lead Sponsor:
Shenzhen Third People's Hospital
Conditions:
Hospitalized Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Short PIVC (intravenous indentation needle) accounts for more than 50% of clinical infusion tools, but long PIVC is rarely used and studied in China. This study aims to explore the application charact...
Detailed Description
The control group will receive a new 24G or 22G short peripheral venous catheter for puncture using direct view aseptic technique, while the intervention group will be implanted with a new long periph...
Eligibility Criteria
Inclusion
- A male or female aged 18 years or older who is able and willing to give written informed consent;
- Identification of the patient's medical diagnosis based on the competent physician and the study nurse at any time during the hospital stay, and judgment that the duration of peripheral intravenous infusion therapy needs to exceed 4 days;
- Subjects with good compliance and can cooperate with catheter maintenance and observation.
Exclusion
- Patients who are delirious and unable to cooperate;
- Patients requiring central venous access;
- Patients suffering from connective tissue diseases or blood diseases;
- Patients allergic to catheters or dressings;
- any subject in a condition deemed by the investigator to interfere with the evaluation of results or pose a health risk to the subject.
Key Trial Info
Start Date :
December 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06503822
Start Date
December 5 2023
End Date
December 31 2024
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deng Qiuxia
Shenzhen, Guangdong, China